‘Black Friday is here’: Holiday sales are already on, with record-breaking deals
Holiday sales are starting earlier this year as retailers try to unload excess inventory and entice shoppers worried about inflation.
Apple, Goldman Sachs introduce interest-bearing savings accounts as rates rise
Apple continues to expand its consumer financial services offerings as it tries to broaden the ways iPhones can be used.
Biden unveils plan to pay farmers and cities for Colorado River water cuts
The Interior’s program will pay applicants a set amount of money per acre-foot of water that they don’t draw from Lake Mead, the country’s largest reservoir.
Biden unveils plan to pay farmers and cities for Colorado River water cuts
The Interior’s program will pay applicants a set amount of money per acre-foot of water that they don’t draw from Lake Mead, the country’s largest reservoir.
Netflix will charge $6.99 a month for new ad-supported plan starting Nov. 3 in U.S.
Netflix is debuting its advertising-supported subscription plan on Nov. 3 in the U.S. at $6.99 per month.
Parkland school shooting: Jury recommends life in prison without parole for gunman, rejects the death penalty
The shooter had pleaded guilty last October to 17 counts of murder in the deaths of 14 students and three staffers in the 2018 Valentine’s Day massacre at Marjory Stoneman Douglas High School in Parkland, Florida.
New York AG asks judge to bar Trump from moving assets to new company he formed amid fraud lawsuit
New York Attorney General Letitia James is seeking at least $250 million in penalties from the Trump Organization, Donald Trump and three of his adult children.
Meta named a top pick at AllianceBernstein, which says shares could surge more than 50% from here
Wall Street is too negative on the stock ahead of a critical earnings season for the social media company, the firm said.
Nike is a buy that’s poised for a comeback beyond 2022, Raymond James says
The investment bank said demand for the sports apparel brand remains robust.
Biogen’s Alzheimer’s drug could be more competitive than peers, Stifel says in upgrade to buy
Biogen’s new Alzheimer’s treatment could lead to even stronger gains for the biotech company going forward, according to Stifel.
